Splenic infarction after N-butyl-2-cyanoacrylate injection for gastric varices: why does it happen?

Abstract	Recent guidelines and consensus reports recommend endoscopic injection therapy with N-butyl-2-cyanoacrylate as the first-line treatment for bleeding-isolated gastric varices and gastroesophageal varices types 1 and 2. Embolization is a rare but serious complication of cyanoacrylate injection, which may be fatal in some cases. Herein, we present a patient who developed splenic infarction after N-butyl-cyanoacrylate injection for gastroesophageal varices type 2 and discuss the potential reasons and tips to prevent the occurence of embolization.
Authors	Aydin S Köksal, Ertuğrul Kayaçetin, Serkan Torun, Vedat Erkan, Riza S Ökten
Journal	Surgical laparoscopy, endoscopy & percutaneous techniques (Surg Laparosc Endosc Percutan Tech) Vol. 23 Issue 5 Pg. e191-3 (Oct 2013) ISSN: 1534-4908 [Electronic] United States
PMID	24105294 (Publication Type: Case Reports, Journal Article, Technical Report)
Chemical References	Sclerosing Solutions Enbucrilate
Topics	Adult Enbucrilate (administration & dosage, adverse effects) Esophageal and Gastric Varices (therapy) Female Gastroscopy (methods) Humans Injections, Intralesional Sclerosing Solutions (administration & dosage, adverse effects) Splenic Infarction (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!